588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tuspetinib Acute Myeloid Leukemia	Aptose Biosciences Inc.	P1/2	CC (45)
Vcar33 Acute Myeloid Leukemia	Vor Biopharma	P1/2	CC (45)
vor33 Acute Myeloid Leukemia	Vor Biopharma	P1/2	CC (45)
Zn-D5 Zn-C3 Acute Myeloid Leukemia	K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.	P1/2	CC (45)
Γδ T Cells Acute Myeloid Leukemia	Chinese PLA General Hospital	P1/2	CC (45)
prt2527 Acute Myeloid Leukemia	Prelude Therapeutics	P1	CC (44)
Zanubrutinib Acute Myeloid Leukemia	Prelude Therapeutics	P1	CC (44)
Acetylcysteine Acute Myeloid Leukemia	Peking University People's Hospital	P2	CC (43)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CC (43)
Amg 553 Acute Myeloid Leukemia	Amgen	P1	CC (43)
Anti-Cd123 Car Nk Cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Anti-Cd33 Cart Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (43)
Anti-Cll-1 Car Nk Cells Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	CC (43)
Anti-Flt3 Car-T Cells Acute Myeloid Leukemia	Hemogenyx Pharmaceuticals LLC	P1	CC (43)
Anti-Lilra6 Car-T Cells Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	CC (43)
Apl-4098 Acute Myeloid Leukemia	Apollo Therapeutics Ltd	P1	CC (43)
Autologous Anti-Cd83 Car T-Cells Acute Myeloid Leukemia	Roswell Park Cancer Institute	P1	CC (43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Autologous Fl-33 Car T Therapy Acute Myeloid Leukemia	Beijing GoBroad Hospital	P1	CC (43)
Autx-703 Acute Myeloid Leukemia	Auron Therapeutics, Inc.	P1	CC (43)
Azenosertib Acute Myeloid Leukemia	K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.	P1/2	CC (43)
b7-h3 target, car gene modified gdt cell Acute Myeloid Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P1	CC (43)
Bosutinib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
BP1002 Acute Myeloid Leukemia	Bio-Path Holdings, Inc.	P1	CC (43)
bp1002; liposomal bcl-2 antisense oligodeoxynucleotide Acute Myeloid Leukemia	Bio-Path Holdings, Inc.	P1	CC (43)
Bsb-2002 Acute Myeloid Leukemia	BlueSphere Bio, Inc	P1	CC (43)
Bugitinib Acute Myeloid Leukemia	Shenzhen University General Hospital	P2	CC (43)
BX2 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (43)
bx3 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (43)
BX4 Acute Myeloid Leukemia	Institut Paoli-Calmettes	P2	CC (43)
Cart123 Cells Acute Myeloid Leukemia	University of Pennsylvania	P1	CC (43)
cb-012 Acute Myeloid Leukemia	Caribou Biosciences, Inc.	P1	CC (43)
Cbx-250 Acute Myeloid Leukemia	Crossbow Therapeutics, Inc.	P1	CC (43)
cd371-specific/ysnvz/i-18 car t cells Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1	CC (43)
CD64 CAR T Cells Acute Myeloid Leukemia	University of Colorado, Denver	P1	CC (43)
cd70 car-nk Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Ceramide Nanoliposome Acute Myeloid Leukemia	Keystone Nano, Inc	P1	CC (43)
Ciml-Nk Cell Therapy Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Cln-049 Acute Myeloid Leukemia	Cullinan Therapeutics Inc.	P1	CC (43)
Cpx-315 Acute Myeloid Leukemia	Centre Hospitalier Universitaire de Nice	P2	CC (43)
Cryopreserved Be Car33 T Cells Acute Myeloid Leukemia	Great Ormond Street Hospital for Children NHS Foundation Trust	P1	CC (43)
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions Acute Myeloid Leukemia	Michael Pulsipher	P2	CC (43)
Ebx-102 Acute Myeloid Leukemia	Imperial College London	P2	CC (43)
Erwinia L-Asparaginase Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CC (43)
Eth-155008 Acute Myeloid Leukemia	Shengke Pharmaceuticals (Jiangsu) Limited, China	P1	CC (43)
Fedratinib Acute Myeloid Leukemia	University of Washington	P2	CC (43)
fl33-03 car-t therapy Acute Myeloid Leukemia	Beijing GoBroad Hospital	P1	CC (43)

Showing 251 to 300 of 588 assets

PreviousPage 6 of 12Next